Literature DB >> 22076551

Are enterococci playing a role in postoperative peritonitis in critically ill patients?

P Seguin1, C Brianchon, Y Launey, B Laviolle, N Nesseler, P-Y Donnio, Y Malledant.   

Abstract

This prospective non-interventional study is aimed at evaluating the role of enterococci in the postoperative course of postoperative peritonitis (POP) and the predictive factors for isolating Enterococcus spp. All adult patients, hospitalized in intensive care, who had POP between September 2006 and February 2010 were analysed. The patients' baseline clinical characteristics and microbiological and surgical characteristics of the first episode of POP were recorded. The rates of surgical and non-surgical complications and mortality were studied. A total of 139 patients were analysed and Enterococcus spp. were recovered in 61 patients (43%). The presence of enterococci was associated with significantly more intra-abdominal abscesses (26% vs 12%, p=0.025), but did not affect the rate of reoperation or mortality. Antibiotic use before reoperation was the only independent predictive factor for isolating enterococci (OR=2.19, CI95%: 1.02-4.70, p<0.043). Although mortality was not affected by the presence of Enterococcus spp., a higher rate of intra-abdominal abscess was found, suggesting that enterococci play a significant role in postoperative peritonitis, but the need to treat them remains to be determined. Previous antibiotic use before reoperation was a key factor in predicting the subsequent recovery of enterococci.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076551     DOI: 10.1007/s10096-011-1467-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  22 in total

1.  Acute renal failure: time for consensus.

Authors:  R Bellomo; J Kellum; C Ronco
Journal:  Intensive Care Med       Date:  2001-10-31       Impact factor: 17.440

2.  Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy.

Authors:  P Seguin; B Laviolle; C Chanavaz; P-Y Donnio; A-L Gautier-Lerestif; J-P Campion; Y Mallédant
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

Review 3.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

4.  Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections.

Authors:  S M Cohn; P A Lipsett; T G Buchman; W G Cheadle; J W Milsom; S O'Marro; A E Yellin; S Jungerwirth; E V Rochefort; D C Haverstock; S F Kowalsky
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

5.  Antimicrobial therapy of experimental intraabdominal sepsis.

Authors:  W M Weinstein; A B Onderdonk; J G Bartlett; T J Louie; S L Gorbach
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

6.  Microbial synergy in experimental intra-abdominal abscess.

Authors:  A B Onderdonk; J G Bartlett; T Louie; N Sullivan-Seigler; S L Gorbach
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

7.  Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial.

Authors:  R J Burnett; D C Haverstock; E P Dellinger; H H Reinhart; J M Bohnen; O D Rotstein; S B Vogel; J S Solomkin
Journal:  Surgery       Date:  1995-10       Impact factor: 3.982

8.  Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis.

Authors:  Albert Sotto; Jean Yves Lefrant; Pascale Fabbro-Peray; Laurent Muller; Jérôme Tafuri; Francis Navarro; Michel Prudhomme; Jean Emmanuel De La Coussaye
Journal:  J Antimicrob Chemother       Date:  2002-10       Impact factor: 5.790

9.  Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.

Authors:  Joseph S Solomkin; Albert E Yellin; Ori D Rotstein; Nicolas V Christou; E Patchen Dellinger; Jose M Tellado; Osvaldo Malafaia; Alvaro Fernandez; Kyuran A Choe; Alexandra Carides; Vilas Satishchandran; Hedy Teppler
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

10.  Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.

Authors:  Joseph S Solomkin; John E Mazuski; John S Bradley; Keith A Rodvold; Ellie J C Goldstein; Ellen J Baron; Patrick J O'Neill; Anthony W Chow; E Patchen Dellinger; Soumitra R Eachempati; Sherwood Gorbach; Mary Hilfiker; Addison K May; Avery B Nathens; Robert G Sawyer; John G Bartlett
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

View more
  4 in total

Review 1.  Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.

Authors:  Dirk Vogelaers; Stijn Blot; Andries Van den Berge; Philippe Montravers
Journal:  Drugs       Date:  2021-05-26       Impact factor: 9.546

Review 2.  [Enterococci and surgical site infections : Causal agent or harmless commensals?]

Authors:  J Pochhammer; A Kramer; M Schäffer
Journal:  Chirurg       Date:  2017-05       Impact factor: 0.955

3.  Essentials for selecting antimicrobial therapy for intra-abdominal infections.

Authors:  Stijn Blot; Jan J De Waele; Dirk Vogelaers
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

4.  Risk factors for mortality in postoperative peritonitis in critically ill patients.

Authors:  Yoann Launey; Benjamin Duteurtre; Raphaëlle Larmet; Nicolas Nesseler; Audrey Tawa; Yannick Mallédant; Philippe Seguin
Journal:  World J Crit Care Med       Date:  2017-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.